1. List of active ingredients that need to have bioequivalent study in the registration dossier
| No | Active substance |
| 1 | Amlodipine |
| 2 | Azithromycin |
| 3 | Carbamazepine |
| 4 | Cefixime |
| 5 | Cefuroxime axetil |
| 6 | Clarithromycin |
| 7 | Glibenclamide |
| 8 | Gliclazide |
| 9 | Metformin |
| 10 | Metoprolol |
| 11 | Nifedipine |
| 12 | Rifampicine |
| 13 | Amoxicillin + Clavulanic acid |
| 14 | Carvedilol |
| 15 | Cefpodoxime |
| 16 | Ezetimibe |
| 17 | Irbesartan |
| 18 | Itraconazole |
| 19 | Risperidone |
| 20 | Rosuvastatine |
| 21 | Simvastatine |
| 22 | Sulpiride |
| 23 | Sultamicilline |
| 24 | Telmisartan |
| 25 | Valproate sodium |
| 26 | Fenofibrate |
2. List of dosage forms that need to have bioequivalent study in registration dossier
– Generic drugs in the form of immediate release dosage, including active substance mentioned in table above.
– Generic drugs in the form of modified release dosage (gastro-resistant, prolonged release, multiphasic release, intramuscular/ subcutaneous depot, transdermal drug delivery system)